OPTN News

4/19/24: The OPTN announces an update to median MELD at transplant (MMaT) values, which affect many liver transplant candidates with exception scores.

4/18/24: OPTN is seeking feedback on a proposed bylaw addition that would establish a code of conduct for OPTN volunteers.

4/17/24: Access “Medical Device Reporting (MDR) Reporting Requirements,” a presentation by the Food and Drug Administration (FDA) to OPTN committee members.

4/17/24: Access “Regulation of Allograft Heart Valves,” a presentation by the FDA to the OPTN Operations and Safety Committee on July 27, 2023.

4/17/24: Access a HRSA and CMS webinar soliciting feedback on the Organ Transplantation Affinity Group (OTAG)'s framework, purpose, goals, and action plan.

4/15/24: Read recommendations from the OPTN Membership and Professional Standards Committee (MPSC) on reporting patient safety events and other topics.

4/15/24: Learn about the pre-transplant mortality rate ratio, a new risk-adjusted pre-transplant performance monitoring metric, to take effect July 25, 2024.

4/15/24: Learn about the OPTN Executive Committee's formation of two ad hoc work groups: the Code of Conduct Work Group and the OPTN Prioritization Work Group.

4/9/24: Read an important message from the OPTN Board President, Dianne LaPointe Rudow, ANP-BC, DNP, FAAN, on OPTN Board independence.

3/11/24: Read a data monitoring report showing that lung transplants for blood type O increased after implementation of a modified blood type rating scale.